CATALOGO DEI PRODOTTI DELLA RICERCA

GIACOPUZZI, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.234
NA - Nord America 4.078
AS - Asia 3.306
SA - Sud America 507
AF - Africa 135
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.983
RU - Federazione Russa 2.461
SG - Singapore 1.356
CN - Cina 1.041
GB - Regno Unito 939
IT - Italia 499
BR - Brasile 412
HK - Hong Kong 279
DE - Germania 254
SE - Svezia 252
IE - Irlanda 249
VN - Vietnam 240
FR - Francia 194
FI - Finlandia 153
KR - Corea 114
JP - Giappone 52
UA - Ucraina 49
CA - Canada 47
TR - Turchia 45
ES - Italia 41
IN - India 36
AR - Argentina 34
NL - Olanda 34
TG - Togo 32
AT - Austria 27
BJ - Benin 26
ID - Indonesia 25
ZA - Sudafrica 25
MX - Messico 24
PL - Polonia 16
IQ - Iraq 14
LT - Lituania 14
IL - Israele 13
AU - Australia 12
BD - Bangladesh 12
CL - Cile 12
EC - Ecuador 12
AE - Emirati Arabi Uniti 11
CO - Colombia 11
BE - Belgio 10
PY - Paraguay 10
UZ - Uzbekistan 10
IR - Iran 9
MA - Marocco 9
NO - Norvegia 9
DZ - Algeria 8
PK - Pakistan 8
SC - Seychelles 8
CZ - Repubblica Ceca 7
EG - Egitto 6
JO - Giordania 6
KE - Kenya 6
UY - Uruguay 6
EU - Europa 5
PE - Perù 5
PT - Portogallo 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GR - Grecia 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
VE - Venezuela 4
AO - Angola 3
ET - Etiopia 3
LK - Sri Lanka 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
SI - Slovenia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UG - Uganda 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
LU - Lussemburgo 1
MK - Macedonia 1
MR - Mauritania 1
NI - Nicaragua 1
PR - Porto Rico 1
Totale 13.275
Salva come PNG Salva come JPEG
Città #
Southend 796
Moscow 794
Singapore 647
Dallas 491
Chandler 486
Ashburn 397
Hong Kong 277
Jacksonville 264
Dublin 249
Beijing 208
New York 186
Woodbridge 184
Verona 150
Ann Arbor 123
The Dalles 118
Los Angeles 106
Ho Chi Minh City 92
Jinan 76
Lawrence 73
Princeton 73
Munich 70
Wilmington 70
Helsinki 59
Redmond 56
Houston 52
Nanjing 52
São Paulo 47
Tokyo 47
Shenyang 46
Milan 41
Buffalo 40
Hanoi 40
Hebei 40
Seoul 39
London 38
Redondo Beach 35
Changsha 32
Lomé 32
Sindelfingen 30
Zhengzhou 29
Columbus 28
Guangzhou 27
Santa Clara 27
Tianjin 27
Cotonou 26
Seattle 25
Dong Ket 24
Amsterdam 22
Haikou 22
Rome 21
Atlanta 20
Brooklyn 20
Denver 20
Frankfurt am Main 20
Hangzhou 20
Orem 20
Nanchang 19
San Francisco 19
Turku 19
Madrid 18
Vienna 18
Washington 17
Jiaxing 16
Taizhou 16
Chennai 15
Johannesburg 15
Ningbo 15
Ankara 14
Council Bluffs 14
Montreal 14
Nuremberg 14
Taiyuan 14
Tombolo 14
Warsaw 14
Poplar 13
Redwood City 13
Stockholm 13
Boston 12
Jakarta 12
Lappeenranta 12
Boardman 11
Manchester 11
Phoenix 11
Rio de Janeiro 11
Toronto 11
Brussels 10
Chicago 10
Dongguan 10
San Jose 10
Bologna 9
Shanghai 9
Belo Horizonte 8
Fuzhou 8
Mexico City 8
Mumbai 8
Norwalk 8
Padova 8
Tashkent 8
Bedford 7
Biên Hòa 7
Totale 7.597
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 288
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 273
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 235
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 186
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 185
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 184
Adenocarcinoma of the esophagogastric junction 184
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 176
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 173
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 170
Thoracic Aortic Pseudoaneurysm after Esophageal Perforation and Mediastinitis Caused by Accidental Ingestion of a Mutton Bone: A Case Report on Staged Endoscopic and Endovascular Treatments 169
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 164
Changing clinical and pathological features of gastric cancer over time. 163
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 163
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 158
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 158
Outcomes after Surgical Treatment of Oesophagogastric Cancer with Synchronous Liver Metastases: A Multicentre Retrospective Cohort Study 156
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 154
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 152
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 152
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 150
Textbook outcome following oesophagectomy for cancer: international cohort study 145
Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. 145
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 145
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 143
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 143
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 142
Western strategy for EGJ carcinoma 141
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 140
Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us? 140
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 139
Complications after gastrectomy for cancer: Italian perspective 136
Feasibility and safety of an enhanced recovery protocol (ERP) for upper GI surgery in elderly patients (≥ 75 years) in a high-volume surgical center 136
Adenocarcinoma of the esophagogastric junction; going up or down? 135
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 134
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 134
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 133
Gastric conduit perforation after Ivor Lewis esophagectomy successfully treated with endoscopic vacuum therapy (E-VAC): a case report 132
Tailored treatment for signet ring cell gastric cancer 130
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 130
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 130
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 129
Lymphadenectomy: how to do it? 127
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 126
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 126
Proximal Gastrectomy: Technical Notes 125
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 125
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial 125
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 123
Comparison of outcomes of multiple platforms for assisted robotic-prostatectomy: rationale and design 122
Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System. Ann Surg Oncol. 120
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 120
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 118
Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre 115
Super-extended (D3) lymphadenectomy in advanced gastric cancer . 115
L’ espressione di BIRC3 come predittore di resistenza alla chemioradioterapia neoadiuvante nell’adenocarcinoma del cardias e nel carcinoma squamoso dell’esofago 115
Esophageal surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it 115
Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA) 114
International consensus on a complications list after gastrectomy for cancer 112
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 111
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 111
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 111
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 110
Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery 109
Indexes of surgical quality in gastric cancer surgery: experience of an Italian network 108
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 107
Severe necrotic and septic pancreatitis. Indications to endoscopic surgical and nutritional therapy 106
Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. 105
Long term results of ajuvant treatment in epidermoid carcinoma of the thoracic esophagus 104
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study 104
Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study 104
Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study 103
Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal. 102
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 99
The "Weekday Effect" on Enhanced Recovery after Surgery Protocol for Gastrectomy 98
Active surveillance for clinical complete responders after chemoradiotherapy for oesophageal squamous cell carcinoma 98
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 97
Treatment of esophago-gastric junction adenocarcinoma 97
Long-Term Results with Surgery Alone and Multimodal Treatments 96
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma 95
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 94
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 94
Robotic-assisted surgical staging with sentinel node biopsy for apparently early-stage endometrial cancer using the modular multi-arm surgical robot system Versius® (Cambridge Medical Robots): a case series 91
Major vessel resection for complete cytoreduction in primary advanced and recurrent ovarian malignancies: A case series and systematic review of the literature - pushing the boundaries in oncovascular surgery 90
Risultati preliminari del trattamento neoadiuvante dell’adenocarcinoma del giunto esofago-gastrico. 89
Cutoff values of major surgical complications rates after gastrectomy 87
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 86
Clinical outcomes of patients with complicated post-operative course after gastrectomy for cancer: a GIRCG study using the GASTRODATA registry 84
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 83
Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis 82
Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot 82
Prosthetic voice rehabilitation after laryngoesophagectomy: surgical and functional outcomes 81
Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population-on behalf of the Italian Research Group for Gastric Cancer 80
Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases 78
Is a robot surgeon with AI the ideal surgeon? A philosophical analysis 78
Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study 78
Follow-up after gastrectomy for cancer. An appraisal of the Italian Research Group for Gastric Cancer 73
MULTICENTER STUDY ON THE INCIDENCE AND TREATMENT OF MEDIASTINAL LEAKS AFTER ESOPHAGECTOMY (MUMELE 2) 67
RAMIE: tradition drives innovation-feasibility of a robotic-assisted intra-thoracic anastomosis 64
The green indocyanine: the meaning of one tracer for the intra-peri operative imaging and vascular evaluation in the reconstructive surgery of head and neck: an experimental multidisciplinary study 59
Totale 12.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.095
article - articoli 46.436
book - libri 484
conference - conferenze 428
curatela - curatele 0
other - altro 373
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.374
Totale 98.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 0 75 32 27 42 60 69 41
2021/2022549 28 156 1 48 27 25 8 40 15 20 31 150
2022/20231.459 82 152 133 217 115 373 5 105 179 17 32 49
2023/20241.010 25 69 70 108 90 203 48 60 24 69 189 55
2024/20252.627 122 143 140 414 141 154 203 132 339 200 187 452
2025/20265.250 488 376 485 1.379 2.097 425 0 0 0 0 0 0
Totale 13.457